Boston Scientific Strikes Back In Stent Trial

Law360, New York (October 16, 2007, 12:00 AM EDT) -- With trial ongoing, Boston Scientific Corp. is seeking judgment as a matter of law in its battle with Cordis Corp. over stent patents, arguing that no reasonable juror could find in favor of the Johnson & Johnson subsidiary.

In a motion filed Tuesday in the U.S. District Court for the Northern District of California, Boston Scientific asked for judgment as a matter of law on Cordis' claim of infringement of the so-called Fontirroche patent and Cordis' defense that the so-called Kastenhofer patents are invalid under the...
To view the full article, register now.